Human endogenous retroviruses:
ammunition for myeloid cells in
neurodegenerative diseases?
Joel Gruchot, David Kremer, Patrick Küry
Department of Neurology, Neuroregeneration, Medical Faculty,
Heinrich-Heine-University, Düsseldorf, Germany
Online:2020-06-15
Published:2020-07-02
Contact:
Patrick Küry, PhD, kuery@uni-duesseldorf.de.
Supported by:
Research on myelin repair and HERVs in the laboratory of PK was supported by the French societies ARSEP (Fondation pour l’Aide à la Recherche sur la Sclérose en Plaques) and AFM (Association Française Contre les Myopathies), by DMSG Ortsvereinigung Düsseldorf und Umgebung e.V. as well as by Geneuro. JG is a student of the iBrain graduate school and PK and JG are supported by the Stifterverband/Novartisstiftung. DK was funded by the Deutsche Forschungsgemeinschaft (DFG) while carrying research on HERVs at Cleveland Clinic. The MS Center at the Department of Neurology is supported in part by the Walter and Ilse Rose Foundation and the James and Elisabeth Cloppenburg, Peek, and Cloppenburg Düsseldorf Stiftung.
Joel Gruchot, David Kremer, Patrick Küry. Human endogenous retroviruses:
ammunition for myeloid cells in
neurodegenerative diseases?[J]. Neural Regeneration Research, 2020, 15(6): 1043-1044.